您当前的位置：
首页 >
文章列表页 >
Inhibition of Ingredients in Jiedu Huoxue Chinese Medicine Compound on Macrophage Inflammatory Response Induced by LPS
更新时间：2024-01-04

    • Inhibition of Ingredients in Jiedu Huoxue Chinese Medicine Compound on Macrophage Inflammatory Response Induced by LPS

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 23, Issue 1, Pages: 25-29(2017)

    • DOI：10.13422/j.cnki.syfjx.2017010025    

      CLC： R285

    • Published：2017

    移动端阅览

  • LIU Zhao, ZHONG Ju-ying, GAO Er-ning, et al. Inhibition of Ingredients in Jiedu Huoxue Chinese Medicine Compound on Macrophage Inflammatory Response Induced by LPS[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(1): 25-29. DOI： 10.13422/j.cnki.syfjx.2017010025.

  •  
  •  

0

Views

6

下载量

4

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effects of Effective Component Groups of Qingfei Litan Prescription on Acute Lung Injury Rats
Jiebiao Qingli Decoction Regulates TLR7/MAPK/NF-κB Pathway to Prevent and Treat Pneumonia Induced by IAV Infection
Effect of Compatibility of Effective Monomer Components of Fujin Shengjisan on Angiogenesis of HUVEC Based on Uniform Design
Optimization and Mechanism Exploration of Tusizi Prescription for Ovarian Reserve Function Based on Uniform Design Method
Mechanism of Yantiao Prescription in Treating Lipopolysaccharide-induced Acute Lung Injury Based on Arachidonic Acid Metabolic Pathways

Related Author

LIU Guan-bin
PAN Jun-hui
WANG Peng
LI Hang
MING Yu
MA Yichuan
YAO Ruiqi
CHAO Yan

Related Institution

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences
Shenzhen Bao'an Authentic Traditional Chinese Medicine Therapy Hospital
Shenzhen Nanshan District Hospital of Traditional Chinese Medicine
Beijing Oriental Yunjia Pharmaceuticals Co. Ltd.
Clinical Research Center for Respiratory Diseases，China-Japan Friendship Hospital
0